Document is current
Any future updates will be listed below
-
Authors
Zoltowska, Katarzyna Marta https://orcid.org/0000-0001-5853-3465
Bandera, Julia https://orcid.org/0009-0000-1104-7232
Hamed, Mohamed Belal https://orcid.org/0000-0002-6383-4147
Enzlein, Thomas https://orcid.org/0000-0003-1789-4090
Hopf, Carsten https://orcid.org/0000-0003-0802-6451
Ryan, Natalie S. https://orcid.org/0000-0003-0361-7455
Chávez-Gutiérrez, Lucía https://orcid.org/0000-0002-8239-559X
-
Funding
Funding for this research was provided by:
Stichting Alzheimer Onderzoek (20220007)
Deutsche Forschungsgemeinschaft (INST874/9-1)
UK Dementia Research Institute at UCL
UK NIHR UCLH Biomedical Research Centre
Dominantly Inherited Alzheimer Network
Fonds Wetenschappelijk Onderzoek (G008023N)
- License Information
-
More Information
Article History
Received: 31 March 2025
Accepted: 18 October 2025
First Online: 26 November 2025
Declarations
:
: Not applicable.
: Not applicable.
: KMZ, JB, MBH, TE, CH and NSR declare no competing interests. LGC is scientific founder of TRIM and reports consultancy for Roche and Astex Pharmaceuticals in the last 3 years.
